- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr John Fox Discusses Expanding Comprehensive Genomic Profiling Across Several Cancers
John Fox, MD, MHA, vice president of Clinical Transformation at Spectrum Health, reacts to the National Comprehensive Cancer Network's call to expand comprehensive genomic testing across several cancers.
John Fox, MD, MHA, vice president of cinical transformation at Spectrum Health, reacts to the National Comprehensive Cancer Network's (NCCN's) call to expand comprehensive genomic testing across several cancers.
Transcript
At the most recent NCCN Annual Meeting, guidelines called for expanded comprehensive molecular profiling across several cancers. Do these changes present new reimbursement challenges?
The NCCN has recommended that we do comprehensive molecular profiling on more and more cancer types. It’s fascinating because the cost of genomic profiling is now in the range of $2500 to $3000. If you look at the cost of the therapies we’re using, they may be, if you’re using a monoclonal antibody, $8000, $10,000, $15,000 a month, and if we’re using those in combination, it’s even more. So, if in fact those molecular profiles help better identify which patients are likely to respond to which therapies, it’s a good value, because they’re spending thousands, tens of thousands of dollars a month on treatment, that if ineffective, is a waste of dollars and a waste of resources and a cost to the patient.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More
